IVERIC bio, Inc. Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
IVERIC bio, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • IVERIC bio, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $400K, a 33.3% increase year-over-year.
  • IVERIC bio, Inc. Operating Lease, Payments for the twelve months ending March 31, 2023 was $1.5M.
  • IVERIC bio, Inc. annual Operating Lease, Payments for 2022 was $1.4M, a 100% increase from 2021.
  • IVERIC bio, Inc. annual Operating Lease, Payments for 2021 was $700K, a 16.7% increase from 2020.
  • IVERIC bio, Inc. annual Operating Lease, Payments for 2020 was $600K, a 40% decline from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.4M +$700K +100% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $700K +$100K +16.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $600K -$400K -40% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $1M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.